Trimethylsilyl triflate → 1-(2,3,5-Tri-O-benzyl-beta-D-ribofuranosyl)-2,4,5,6-tetrachlorobenzimidazole
Reaction equation
[N+](C1C=CC(C(O[C@@H:11]2[O:31][C@H:30]([CH2:32][O:33][CH2:34][C:35]3[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=3)[C@@H:21]([O:22][CH2:23][C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)[C@H:12]2[O:13][CH2:14][C:15]2[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=2)=O)=CC=1)([O-])=O.[Cl:43][C:44]1[NH:45][C:46]2[C:52]([Cl:53])=[C:51]([Cl:54])[C:50]([Cl:55])=[CH:49][C:47]=2[N:48]=1.[Si](OS(C(F)(F)F)(=O)=O)(C)(C)C>C(Cl)Cl.CC#N.CCOC(C)=O>[CH2:14]([O:13][C@@H:12]1[C@H:21]([O:22][CH2:23][C:24]2[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=2)[C@@H:30]([CH2:32][O:33][CH2:34][C:35]2[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=2)[O:31][C@H:11]1[N:48]1[C:47]2[CH:49]=[C:50]([Cl:55])[C:51]([Cl:54])=[C:52]([Cl:53])[C:46]=2[N:45]=[C:44]1[Cl:43])[C:15]1[CH:16]=[CH:17][CH:18]=[CH:19][CH:20]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 75 °C
Procedure
For the preparation of 1-O-chloro-2,3,5-tri-O-benzyl-D-ribofuranose, HCl gas was allowed to pass through a solution of 1-O-p-nitrobenzoyl-2,3,5-tri-O-benzyl-β-D-ribofuranose (1.479 g, 2.6 mmol) in 10 mL of dry CH2Cl2 at 0° C. for 15 min. The resulting suspension was quickly filtered and the filtrate was evaporated. The residue was coevaporated with dry MeCN and then dissolved in 5 mL of dry MeCN for immediate use in the subsequent glycosylation reaction. To a mixture of 13 (0.512 g, 2 mmol) in 10 mL of dry MeCN, was added 0.5 mL (2 mmol) of BSA. The reaction mixture was stirred at 75° C. for 20 min. This solution was treated with the above MeCN solution of the blocked carbohydrate and 0.464 mL (2.4 mmol) of TMSOTf at 70° C. for 20 min. The reaction mixture was cooled and diluted with EtOAc (50 mL). The EtOAc solution was washed with sat. NaHCO3 solution (50 mL×2), sat. NaCl solution (50 mL), dried (Na2SO4), and evaporated. The residue was chromatographed on a silica column (1.9×38 cm, eluted with hexane, 10%, 15% EtOAc/hexane). Evaporation of fractions 30-37 (15 mL per fraction) gave 0.593 g (45%) of 91a as a colorless syrup. MS: (El) m/e 658.0780 (2%, M+ =658.0774), 1H NMR (DMSO-d6): d 7.93 (s, 1, 7-H), 7.35, 6.92 (2×m, 15, 3×PhCH2), 5.99 (d, 1, 1'-H, J1'-2' =8.0 Hz), 4.72, 4.58, 4.35 (3×m, 9, 2'-H, 3'-H, and 3×PhCH2), 3.76 (dd, 1, 5'-H, J4'-5' =2.0 Hz, J5'-5" =11.0 Hz), 3.65 (dd, 1, 5"-H, J4'-5" =2.5 Hz), 13C NMR (DMSO-d6): d 142.00 (C2), 138.40 (C3a), 137.81. 137.44, 136.74 (3×PhCH2), 131.34 (C7a), 128.08, 128.03. 127.59, 127.40, 127.32, 127.28, 126.97 (3×PhCH2 and C4), 124.64, 122,52 (C5 and C6), 112.65 (C7), 87.46 (C1'), 83.03, 77.08, 74.92 (C2', C3', and C4'), 72.43, 71.44, 71.28 (3×PhCH2), 69.22 (C5'),
Workup
- filtrationThe resulting suspension was quickly filtered
- customthe filtrate was evaporated
- dissolutiondissolved in 5 mL of dry MeCN for immediate use in the subsequent glycosylation reaction
- additionwas added 0.5 mL (2 mmol) of BSA
- temperatureThe reaction mixture was cooled
- washThe EtOAc solution was washed with sat. NaHCO3 solution (50 mL×2), sat. NaCl solution (50 mL)
- dry with materialdried (Na2SO4)
- customevaporated
- customThe residue was chromatographed on a silica column (1.9×38 cm, eluted with hexane, 10%, 15% EtOAc/hexane)
- customEvaporation of fractions 30-37 (15 mL per fraction)
Sources & evidence
- ORD record
- ord-a7e8671cb2ef46baa07260bd9886f707
- Source dataset
- uspto-grants-1998_01
- Patent number
- US05712255
Reaction notes
Loading…